Pandorum Technologies partners with Bharat Biotech's Nucelion to boost exosome therapy manufacturing for Asia-Pacific. This strategic move aims to address unmet global clinical needs with regenerative medicine. Read more.
Kriya Therapeutics, founded by Shankar Ramaswamy, secures over $1.2B in funding despite having no approved gene therapies. The surge sparks comparisons to brother Vivek's past venture. Read the full analysis.
Fitterfly, a division of PB Health, has secured a patent for its PGR technology, aiming to revolutionize personalized diabetes care and improve patient outcomes in India.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.